In pharmacies, starting January 2024, patients can leave with antibiotics for a sore throat or a cystitis without going through a doctor. The pharmacist conducts a rapid diagnostic orientation test (TROD), and if the bacterial origin is confirmed, they dispense the treatment. This measure, designed to address the growing difficulty of obtaining a medical appointment, has redistributed part of the care pathway to the pharmacy.
It well illustrates the type of concrete change that reshapes the daily lives of patients in France, and it deserves close attention to health news throughout the year.
Drug shortages in 2024: the legislative response to stock outages
The previous winter left its mark: empty shelves in pharmacies, common treatments unavailable for weeks. To avoid experiencing these situations again, a first measure required pharmacists to dispense certain medications individually in case of supply shortages. The goal is twofold: to limit the waste of tablets that end up expiring in our cabinets, and to distribute the available stocks among more patients.
The response did not stop there. On February 29, 2024, the National Assembly adopted a bill providing for minimum stocks of medications, with varying durations depending on the products. This shifts from a crisis management logic to an obligation for laboratories to anticipate. To keep track of the evolution of these measures and other substantive issues, the health news on mediccom.org allows you to keep an eye on what is really changing in the care pathway.
HPV vaccination in middle schools: numbers still far from the target
The vaccination campaign against human papillomavirus (HPV) launched in middle schools continued in 2024. On paper, the system is simple: offer vaccination directly at the school to reach as many adolescents as possible. In practice, the results remain mixed.
Public Health France reports that in 2024, 58.4% of girls and 36.9% of boys aged 15 had received at least one dose. The gap between girls and boys persists, and the overall coverage remains insufficient in light of the national target. Several factors explain these results:
- Parental perceptions play a decisive role: some families still hesitate regarding a vaccine perceived as related to their child’s sexuality
- School logistics (consent forms to collect, time slots to organize) hinder deployment in institutions with less medical staff
- The lack of follow-up from general practitioners, who do not always catch up on missed doses during regular consultations
This is far from a simple communication problem. HPV vaccination in middle schools raises the broader question of prevention in schools and the system’s ability to reach populations without regular medical follow-up.
Dengue and tiger mosquito: monitoring vector-borne diseases in metropolitan France
Dengue is still often associated with tropical destinations. In 2024, the metropolitan reality reminded us that mosquito-borne diseases also concern mainland France. The ARS Occitanie recorded 178 imported cases of dengue over the year, along with five indigenous cases contracted directly on the territory.
Five indigenous cases may seem anecdotal. In epidemiology, it is a signal. Each indigenous case means that a local tiger mosquito has bitten an infected person and then transmitted the virus to someone else. The transmission chain is established.
Monitoring relies on a mandatory reporting system and on travelers returning from endemic areas reporting their cases. Specifically, when returning from a country where dengue is circulating and presenting with fever, consulting quickly allows not only for treatment but also to trigger mosquito control operations around the home to break the transmission.
PFAS in drinking water: a significant health issue in 2024
PFAS, these persistent chemical substances nicknamed “forever pollutants,” have taken on an increasing role in health debates. The European directive on drinking water now sets limits for these compounds, and France has established a threshold concerning the sum of 20 substances.
What makes the issue complex is that occasional exceedances vary greatly from one water network to another, depending on the proximity of industrial sites, the nature of the soils, and the treatment capabilities of the plants. A rural community supplied by an aquifer near an old factory may exhibit concentrations well above those of a large urban area equipped with activated carbon filters.
For residents, the challenge is accessing reliable and localized information. Analysis results are published by regional health agencies, but their interpretation requires a minimum of technical context. Following this issue over the months allows for distinguishing between occasional alerts and underlying trends regarding water quality.
Antibiotics in pharmacies and expanded competencies: what this changes in daily life
Let’s return to the measure that opens the article. The dispensing of antibiotics by pharmacists for sore throats and cystitis relies on a rapid test (TROD). If the result indicates a bacterial origin, the treatment is provided without a prescription. The procedure seems smooth, but it raises concrete questions.
A cystitis may sometimes require additional clinical examination, especially in cases of frequent recurrences or atypical symptoms. Several doctors have described this measure as a “band-aid solution,” arguing that it sidesteps the problem of the lack of practitioners instead of solving it. The expansion of pharmaceutical competencies does not replace access to a doctor, it complements it in emergencies.
Other measures that came into effect in 2024 directly impact finances: the free provision of female condoms, partial reimbursement for reusable menstrual products, and the end of the waiting day after a miscarriage. These provisions, less publicized than major medical discoveries, nonetheless change the daily lives of millions of people in France.
The year 2024 will have mixed tangible regulatory advances with health alert signals that deserve regular monitoring. Between drug shortages, the spread of the tiger mosquito, and the monitoring of pollutants in water, public health issues far exceed the scope of medical innovations alone.
